Zenas BioPharma Balance Sheet
NASDAQ: ZBIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Zenas BioPharma financial position
At the end of fiscal 2025, Zenas BioPharma reported total assets of $383.6 million, up 3.7% from a year earlier against total liabilities of $141.5 million. Shareholders' equity stood at $242.1 million, or 63.1% of assets. The company held $110.6 million in cash and equivalents against $78.6 million of debt, a net cash position of $32.0 million.
The current ratio (current assets divided by current liabilities) was 5.61, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.32.
Summary generated from market data by MetaCap's automated system. Methodology
Zenas BioPharma balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 |
|---|---|---|---|
| Cash & Equivalents | 110.64M | 319.74M | 56.86M |
| Short-Term Investments | 232.55M | 31.02M | — |
| Total Current Assets | 351.17M | 355.92M | 59.80M |
| Property, Plant & Equipment | 34.00K | 185.00K | 193.00K |
| Long-Term Investments | 17.27M | — | — |
| Total Assets | 383.64M | 369.97M | 68.18M |
| Accounts Payable | 7.11M | 17.14M | 5.40M |
| Total Current Liabilities | 62.65M | 57.29M | 23.26M |
| Long-Term Debt | 78.64M | — | — |
| Total Liabilities | 141.50M | 57.51M | 43.81M |
| Shareholders' Equity | 242.14M | 312.46M | -225.72M |
| Retained Earnings | -765.13M | -387.39M | -230.40M |
| Total Debt | 78.64M | — | — |
| Net Cash (Debt) | 264.56M | 350.77M | 56.86M |
| Shares Outstanding | 54.49M | 41.79M | 1.58M |
This table shows 3 annual periods of Zenas BioPharma's balance sheet, from FY 2025 back to FY 2023, across 15 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow ZBIO's reporting calendar. What is a balance sheet?